Company profile for NImmune Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NImmune is a late-stage precision immunology biopharmaceutical company that develops best-in-class biomarker-driven immunoregulatory therapeutics. Underpinned by advanced computational modeling and bioinformatics coupled with biomedical research capabilities to pioneer innovation in immunoregulatory drug development, NImmune’s business model enables the rapid and capital-efficient clinical development of high conviction drug...
NImmune is a late-stage precision immunology biopharmaceutical company that develops best-in-class biomarker-driven immunoregulatory therapeutics. Underpinned by advanced computational modeling and bioinformatics coupled with biomedical research capabilities to pioneer innovation in immunoregulatory drug development, NImmune’s business model enables the rapid and capital-efficient clinical development of high conviction drug candidates into New Drug Application (NDA) filing and commercialization.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1800 Kraft Dr Ste 100 Blacksburg, VA 24060
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250506018915/en/NImmune-Biopharma-to-Present-at-DDW25-the-First-Ever-Head-to-Head-Clinical-and-Translational-Results-for-Omilancor-Versus-Leading-Anti-TL1A-in-IBD-Showing-Superiority-and-Complementarity

BUSINESSWIRE
06 May 2025

https://www.businesswire.com/news/home/20250421323133/en/The-NIMML-Institute-and-NImmune-Biopharma-Showcase-How-the-TITAN-X-A.I.-Platform-has-Accelerated-Therapeutic-Development-in-the-Annual-Review-of-Biomedical-Data-Science

BUSINESSWIRE
21 Apr 2025

https://www.businesswire.com/news/home/20250113405332/en

BUSINESSWIRE
13 Jan 2025

https://www.businesswire.com/news/home/20241023953586/en

BUSINESSWIRE
23 Oct 2024

https://www.businesswire.com/news/home/20241007940917/en

BUSINESSWIRE
07 Oct 2024

https://www.businesswire.com/news/home/20240916653788/en

BUSINESSWIRE
16 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty